Fate Therapeutics (FATE) Total Debt (2012 - 2019)

Fate Therapeutics has reported Total Debt for 8 years, with the latest figure at $13.9 million in Q3 2019.

• For the quarter ending Q3 2019, Total Debt fell 6.28% year-over-year to $13.9 million; the trailing twelve-month figure through Sep 2019 stood at $13.9 million (down 6.28% YoY), and the FY2018 full-year result was $14.9 million, up 0.51% from the prior year.
• Total Debt for Q3 2019 stood at $13.9 million, down from $14.9 million in the prior quarter.
• The five-year high for Total Debt was $19.7 million in Q2 2015, with the low at $6.7 million in Q2 2017.
• Historically, Total Debt has averaged $14.7 million across 5 years, with a median of $14.8 million in 2018.
• Annual changes were most pronounced in 2015 — Total Debt surged 2540.08% — and 2017, when it plunged 54.41%.
• Fate Therapeutics' Total Debt stood at $18.2 million in 2015, then sank by 41.4% to $10.7 million in 2016, then jumped by 38.55% to $14.8 million in 2017, then climbed by 0.51% to $14.9 million in 2018, then slipped by 6.4% to $13.9 million in 2019.
• The last three Total Debt figures came in at $13.9 million (Q3 2019), $14.9 million (Q2 2019), and $14.9 million (Q1 2019), per Business Quant data.